Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Rapid Publication Free access | 10.1172/JCI109995

Disruption of the Purine Nucleotide Cycle: A POTENTIAL EXPLANATION FOR MUSCLE DYSFUNCTION IN MYOADENYLATE DEAMINASE DEFICIENCY

Richard L. Sabina, Judith L. Swain, Bernard M. Patten, Tetsuo Ashizawa, William E. O'Brien, and Edward W. Holmes

Howard Hughes Medical Institute Laboratories and Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710

Howard Hughes Medical Institute Laboratories and Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710

Department of Neurology, Baylor College of Medicine, Houston, Texas 77030

Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030

Find articles by Sabina, R. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute Laboratories and Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710

Howard Hughes Medical Institute Laboratories and Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710

Department of Neurology, Baylor College of Medicine, Houston, Texas 77030

Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030

Find articles by Swain, J. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute Laboratories and Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710

Howard Hughes Medical Institute Laboratories and Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710

Department of Neurology, Baylor College of Medicine, Houston, Texas 77030

Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030

Find articles by Patten, B. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute Laboratories and Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710

Howard Hughes Medical Institute Laboratories and Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710

Department of Neurology, Baylor College of Medicine, Houston, Texas 77030

Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030

Find articles by Ashizawa, T. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute Laboratories and Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710

Howard Hughes Medical Institute Laboratories and Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710

Department of Neurology, Baylor College of Medicine, Houston, Texas 77030

Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030

Find articles by O'Brien, W. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute Laboratories and Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710

Howard Hughes Medical Institute Laboratories and Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710

Department of Neurology, Baylor College of Medicine, Houston, Texas 77030

Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030

Find articles by Holmes, E. in: JCI | PubMed | Google Scholar

Published December 1, 1980 - More info

Published in Volume 66, Issue 6 on December 1, 1980
J Clin Invest. 1980;66(6):1419–1423. https://doi.org/10.1172/JCI109995.
© 1980 The American Society for Clinical Investigation
Published December 1, 1980 - Version history
View PDF
Abstract

A patient with symptoms of easy fatigability, postexercise myalgias, and delayed recovery of muscle strength after activity is described. Skeletal muscle from this patient had <1.0% normal myoadenylate deaminase activity and NH3 was not released from muscle after ischemic exercise. In association with this enzyme deficiency, exercise led to a >90% reduction in muscle content of adenine nucleotides. No inosine monophosphate accumulated after exercise and total purine content of the muscle fell to 21% of control. Repletion of the adenine nucleotide pool in this patient was delayed compared to controls, and ATP content had only returned to 68% of control at 165 min after exercise. These studies demonstrate that disruption of the purine nucleotide cycle as a consequence of myoadenylate deaminase deficiency results in marked alterations in ATP content of muscle, and potentially, these changes in ATP content could account for muscle dysfunction in this patient.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1419
page 1419
icon of scanned page 1420
page 1420
icon of scanned page 1421
page 1421
icon of scanned page 1422
page 1422
icon of scanned page 1423
page 1423
Version history
  • Version 1 (December 1, 1980): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts